About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Anticoagulant Reversal Agents
By
George Davis
1,953 views
August 1, 2017
2 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
19:49
Rush University Medical Center
COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…
Feat.
S. Jain
22:57
The France Foundation
Insights into Advances in Nonvalvular Atrial Fibrillation: Exploring…
Feat.
C. Ruff,
J. Walker
34:24
The France Foundation
Insights into Advances in Nonvalvular Atrial Fibrillation: Creating …
Feat.
C. Ruff
14:39
Lankenau
Management of AF patients with ACS
Feat.
P. Kowey,
D. Ice
18:36
The Texas Heart Institute
Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?
Feat.
M. Razavi
57:30
McMaster University Department of Medicine
Five Things Every Internist Should Know About Anticoagulants
Feat.
S. Mithoowani
24:29
University of Miami
Anticoagulating the Challenging Atrial Fibrillation Patient
Feat.
N. Sur
48:35
Houston Methodist DeBakey Heart and Vascular Center
"Pill in Pocket" Anticoagulation for Atrial Fibrillation: …
Feat.
R. Passman
08:29
PERT Consortium 2022
Duration of Anticoagulation: Provoked vs Unprovoked VTE
Feat.
G. Barnes
21:17
Venous Edge
Acute DVT: When to and When Not to Intervene?
Feat.
S. Elias,
C. Pena,
C. Huff,
R. Winokur,
K. BROWN
10:21
NY Endovascular Summit
Medical Management of DVT
Feat.
J. Goldfinger
01:19
Boston Scientific
HEMOCOAT™ Technology: Mechanism of Action
Feat.
A. Finn
06:03
Boston Scientific
HEMOCOAT™ Overview with Dr. Nielsen-Kudsk
Feat.
J. Erik Nielsen-Kudsk
13:26
Boston Scientific
HEMOCOAT™ Technology: Experimental Overview
Feat.
A. Finn
16:11
Jeffrey Weitz
Extended Anticoagulation for VTE
14:44
Stanford Medicine
How Much Atrial Fibrillation Is Too Much: Contemporary and Future Ma…
Feat.
A. Perino
14:16
Penn Medicine Heart and Vascular Center
Stroke Prevention in Atrial Fibrillation
Feat.
D. Goldberg
19:47
Complex Coronary Cases
Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Us…
Feat.
U. Baber
14:47
ACC 2023 Conference Coverage
ACC 2023: Can LAAC Be Considered a True Alternative to OAC?
Feat.
A. Natale
15:49
PERT Consortium 2021
VTE Prevention in Medical Patients
Feat.
S. Schulman